Medical Imaging Corporation

Research Medical Imaging Corporation (6637.TWO) on Bullrun: market cap TWD 1.45B, P/E 9.9, dividend yield 8.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.45B; P/E is 9.9; dividend yield is 8.2%.

Peer valuation comparison

Latest P/E is 9.93x versus a Healthcare sector median of 21.8x (54.5% below).

Latest dividend yield is 8.24% versus a Healthcare sector median of 2.4% (243.3% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.45B9.98.3%4.5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 4.5 TWD, yield 8.2%.

About Medical Imaging Corporation

Medical Imaging Corporation offers imaging hospital equipment leasing and maintenance services in China. The company's products include ultrasound sonography, bone densitometer, emergency rooms and intensive isolation wards, and radiation protection lead plates. It also distributes medical equipment and drugs; and engages in the wholesale and retail of pharmaceuticals and medical equipment, as well as international trade and management consulting activities.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Medical Imaging Corporation's market cap?

Medical Imaging Corporation's market capitalization is TWD 1.45B.

What is Medical Imaging Corporation's P/E ratio?

Medical Imaging Corporation's price-to-earnings (P/E) ratio is 9.9.

Does Medical Imaging Corporation pay a dividend?

Medical Imaging Corporation has a dividend yield of 8.2%.

What does Medical Imaging Corporation do?

Medical Imaging Corporation offers imaging hospital equipment leasing and maintenance services in China. The company's products include ultrasound sonography, bone densitometer, emergency rooms and intensive isolation wards, and radiation protection lead plates. It also distributes medical equipment and drugs; and engages in the wholesale and retail of pharmaceuticals and medical equipment, as well as international trade and management consulting activities. The company was founded in 1992 and is based in Taipei, Taiwan.